Cathy L Budman Selected Research

ecopipam

1/2018	Ecopipam, a D1 receptor antagonist, for treatment of tourette syndrome in children: A randomized, placebo-controlled crossover study.
1/2014	A D1 receptor antagonist, ecopipam, for treatment of tics in Tourette syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cathy L Budman Research Topics

Disease

7	Tics (Tic) 01/2018 - 01/2008
6	Tourette Syndrome (Tourette's Syndrome) 01/2018 - 01/2008
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 02/2013 - 01/2008
1	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 02/2013
1	Tic Disorders (Tic Disorder) 02/2012
1	Hypoxia (Hypoxemia) 06/2006

Drug/Important Bio-Agent (IBA)

2	ecopipamIBA 01/2018 - 01/2014
2	Explosive Agents (Explosives)IBA 02/2013 - 02/2012
1	Dopamine D2 Receptor AntagonistsIBA 01/2018
1	Antipsychotic Agents (Antipsychotics)IBA 07/2014
1	Dopamine D1 Receptors (Dopamine D1 Receptor)IBA 01/2014
1	beta-cyclodextrin tetradecasulfate (CTDS)IBA 02/2013
1	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 01/2008

Therapy/Procedure

1	Surgical Instruments (Clip) 06/2006